DMK Pharmaceuticals Corp
OTC:DMKPQ

Watchlist Manager
DMK Pharmaceuticals Corp Logo
DMK Pharmaceuticals Corp
OTC:DMKPQ
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 10 USD

Operating Margin
DMK Pharmaceuticals Corp

-696.8%
Current
-740%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-696.8%
=
Operating Profit
-25.2m
/
Revenue
3.6m

Operating Margin Across Competitors

No Stocks Found

DMK Pharmaceuticals Corp
Glance View

Market Cap
10 USD
Industry
Pharmaceuticals

Adamis Pharmaceuticals Corp. is a biopharmaceutical company, which engages in the discovery, development, and sale of pharmaceutical, specialty biopharmaceutical, and other drug products. The company is headquartered in San Diego, California and currently employs 11 full-time employees. The firm is focused on developing therapies for opioid use disorder (OUD) and other neuro-based conditions. The Company’s commercial products approved by the United States Food and Drug Administration (FDA) include ZIMHI (naloxone) injection for the treatment of opioid overdose, and SYMJEPI (epinephrine) Injection for use in the emergency treatment of acute allergic reactions, including anaphylaxis. The company has a library of approximately 750 small molecule neuropeptide analogues and a differentiated pipeline. The Company’s lead clinical-stage product candidate, DPI-125, is being studied as a treatment for OUD. The Company’s other development stage product candidates include DPI-221 for bladder control problems and DPI-289 for severe end stage Parkinson’s disease.

DMKPQ Intrinsic Value
Not Available
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-696.8%
=
Operating Profit
-25.2m
/
Revenue
3.6m
What is the Operating Margin of DMK Pharmaceuticals Corp?

Based on DMK Pharmaceuticals Corp's most recent financial statements, the company has Operating Margin of -696.8%.

Back to Top